Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (2)
  • Open Access

    ARTICLE

    Correlation between Syndecan-1 in Inter Category of RACHS-1 Score and Immediate Clinical Outcomes

    Novik Budiwardhana1,*, Indah Kartika Murni2, Eva Miranda Marwali1, Pribadi Wiranda Busro3, Fildza Intan Rizkia4, Muhamad Faza Soelaeman4, Yunita Widyastuti5

    Congenital Heart Disease, Vol.20, No.5, pp. 591-600, 2025, DOI:10.32604/chd.2025.070345 - 30 November 2025

    Abstract Background: Low cardiac output syndrome (LCOS) is a frequent and serious complication after pediatric cardiac surgery. Endothelial glycocalyx (EG) degradation, indicated by elevated syndecan-1, contributes to microvascular dysfunction and postoperative instability. The relationship between syndecan-1 dynamics and surgical risk categories remains unclear. Objective: To examine the association between perioperative syndecan-1 levels and clinical outcomes across Risk Adjustment for Congenital Heart Surgery (RACHS-1) categories. Methods: We analyzed 106 children (RACHS-1 categories 2–4) undergoing elective cardiac surgery with cardiopulmonary bypass (CPB). Syndecan-1 was measured at baseline (T0), 4 h (T4), and 72 h (T72). Outcomes included LCOS, vasoactive inotropic… More >

  • Open Access

    ARTICLE

    Heparanase/Syndecan-1 Axis Regulates the Grade of Liver Cancer and Proliferative Ability of Hepatocellular Carcinoma Cells

    Shengjin Yu, Huiming Lv, Jinhui Zhang, He Zhang, Weiwei Ju, Yu Jiang*, Lijuan Lin*

    Oncologie, Vol.24, No.3, pp. 539-551, 2022, DOI:10.32604/oncologie.2022.024882 - 19 September 2022

    Abstract Background: Although heparanase/syndecan-1 axis is involved in malignant progression of many cancers, its significance in liver cancer is not well understood. In this study, we explored the value of heparanase/syndecan-1 axis expression in liver cancer and the intervention mechanisms that target this axis by inhibiting the proliferation of hepatocellular carcinoma cells. Materials and Methods: We conducted tissue microarray analysis that included 90 primary liver cancer and their corresponding adjacent samples to evaluate the expression of heparanase and syndecan-1 and their correlation with clinicopathologic characteristics. RNA interference and western blot assays were performed to analyze the effect of… More >

Displaying 1-10 on page 1 of 2. Per Page